{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.73","upperLimit":"0.91","value":"0.84"},{"groupId":"OG001","lowerLimit":"0.69","upperLimit":"0.90","value":"0.82"},{"groupId":"OG002","lowerLimit":"0.65","upperLimit":"0.97","value":"0.90"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"57"},{"groupId":"OG002","value":"20"}],"units":"Participants"}],"description":"To investigate whether very early response assessment measured by Fluorodeoxyglucose-PET after 1 cycle of chemotherapy identifies a subject cohort that can be studied in future trials and that is distinguishable from currently defined RER after 2 cycles.","dispersionType":"95% Confidence Interval","groups":[{"description":"All Patients","id":"OG000","title":"Group 1"},{"description":"RER PET-1 positive","id":"OG001","title":"Group 4"},{"description":"RER PET-1 negative","id":"OG002","title":"Group 5"}],"paramType":"NUMBER","populationDescription":"RER with positive PET-1, Event-Free Survival for RER PET-1 positive patients is compared to that of RER with negative PET-1: n=57 PET-1 positive RER patients, compared to 2 events among n=20 PET-1 negative RER patients. Two PET-1 equivocal RER patients (1 with relapse and 1 censored) are not included in this analysis.","reportingStatus":"POSTED","timeFrame":"3 years from enrollment","title":"Event-free Survival for Rapid Early Response (RER) Positron Emission Tomography(PET)-1 Positive, RER PET-1 Negative","type":"SECONDARY","unitOfMeasure":"Probability of survival"}